Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Puerto Rico Business Tribune.
Press releases published on August 13, 2025

Big Attitude Meets Mischief with L.O.L. Surprise!™ and Illumination’s Minions Collab
LOS ANGELES, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Global sensation L.O.L. Surprise!™, the brand from MGA Entertainment (MGA) synonymous with surprise and outrageous, unboxing fun, today announced the drop of an all-new line of L.O.L. Surprise! Loves Minions …

Euronet Worldwide Announces Proposed Private Placement of $850 Million of Convertible Senior Notes
LEAWOOD, Kan., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Euronet Worldwide, Inc. (“Euronet” or the “Company”) (Nasdaq: EEFT), a leading electronic payments provider, today announced that it intends to offer, subject to market conditions and other factors, $850 …

Crown Crafts Announces Financial Results for First Quarter Fiscal 2026
GONZALES, La., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the “Company”) today reported results for the first quarter fiscal year 2026, which ended June 29, 2025. First Quarter Summary Net sales of $15.5 million compared to $16 …

Calian annonce les résultats du troisième trimestre
(Tous les montants dans le communiqué sont en dollars canadiens.) OTTAWA, Ontario, 13 août 2025 (GLOBE NEWSWIRE) -- CalianMD Group Ltd. (TSX : CGY), une société qui fournit des solutions essentielles à la mission, axée sur la défense, l’espace, les soins …

Calian Reports Results for the Third Quarter
(All amounts in release are in Canadian dollars) OTTAWA, Ontario, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Calian® Group Ltd. (TSX:CGY), a mission-critical solutions company focused on defence, space, healthcare and other strategic critical infrastructure sectors …

KP Tissue declares a Quarterly Dividend of $0.18 per Common Share
NOT FOR DISTRIBUTION IN THE U.S.A. OR OVER U.S. WIRE SERVICES MISSISSAUGA, Ontario, Aug. 13, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) announced today that the Board of Directors has declared a quarterly dividend of $0.18 per common share, …

Papiers Tissu KP déclare un dividende trimestriel de 0,18 $ par action ordinaire
NON DESTINÉ À LA PUBLICATION AUX ÉTATS-UNIS NI AUX AGENCES DE TRANSMISSION AMÉRICAINES MISSISSAUGA, Ontario, 13 août 2025 (GLOBE NEWSWIRE) -- Papiers Tissu KP inc. (TSX : KPT) (PTKP) a annoncé aujourd’hui que son conseil d’administration a déclaré un …

KP Tissue Releases Second Quarter 2025 Financial Results
MISSISSAUGA, Ontario, Aug. 13, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) reports the Q2 2025 financial and operational results of KPT and Kruger Products Inc. (Kruger Products). Kruger Products is Canada's leading manufacturer of quality …

Papiers Tissu KP publie ses résultats du deuxième trimestre 2025
MISSISSAUGA, Ontario, 13 août 2025 (GLOBE NEWSWIRE) -- Papiers Tissu KP inc. (« PTKP ») (TSX : KPT) présente ses résultats financiers et ses résultats d’exploitation, ainsi que ceux de Produits Kruger inc. (« Produits Kruger »), du deuxième trimestre de …

Marex Group plc announces second quarter 2025 results
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (‘Marex’ or the ‘Group’; Nasdaq: MRX) a diversified global financial services platform, providing essential liquidity, market access and infrastructure services to clients in the energy, …

Bitcoin Swift Presale Reaches Stage 4 With $580K+ in Volume and Over 2,100 Buyers Ahead of September 18 Deadline
LUXEMBOURG, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Bitcoin Swift (BTC3), a next-generation blockchain project combining programmable rewards, privacy, compliance, and AI-driven efficiency, has advanced to Stage 4 of its ongoing presale. With over 2,100 buyers …

Immatics Announces Second Quarter 2025 Financial Results and Business Update
Anzu-cel (anzutresgene autoleucel, IMA203) PRAME Cell Therapy: One-time infusion continues to show favorable tolerability as well as strong anti-tumor activity and durability in 33 heavily pretreated patients with metastatic melanoma in data from a Phase …

Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to …

Tilray Medical stringe una partnership strategica in Italia per rendere più accessibili gli estratti di cannabis terapeutica
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, una divisione di Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) e leader mondiale nel settore della cannabis terapeutica, impegnata a rafforzare l'alleanza terapeutica tra pazienti e …

Guardian Capital Announces Fund Merger
TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Guardian Capital LP (the “Manager”) today announced that Guardian Canadian Growth Equity Fund (the “Merging Fund”) will be merged into Guardian Canadian Equity Fund (the “Continuing Fund” and together with the …

Greenbacker sells 51 MW distributed solar portfolio, advancing strategic focus on scaled clean energy projects
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Greenbacker, an energy transition-focused investment manager and independent power producer, today announced the sale of a 51.2 MW portfolio of 64 operating solar assets to CleanCapital, a leading independent …

Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results
More than 45 patients enrolled in Emi-Le Phase 1 dose expansion cohorts in post-topoisomerase-1 inhibitor ADC (post-topo-1) triple-negative breast cancer (TNBC) Plan to report initial clinical data from Emi-Le expansion cohorts in second half of 2025 …

Lantronix to Report Fiscal 2025 Fourth Quarter Results on Aug. 27, 2025
IRVINE, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (the “Company”) (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions enabling Edge AI Intelligence, today announced it will release financial results from its fiscal 2025 …

ARS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Accelerating Growth for neffy® (epinephrine nasal spray)
$15.7 million in revenue, including $12.8 million in neffy U.S. net product revenue in second quarter of 2025 Growth for neffy in the U.S. driven by increased payor access with additional near-term growth anticipated from national direct-to-consumer (DTC) …

Kamada Reports Strong Second Quarter and First Half 2025 Financial Results with 11% Year-Over-Year 6-Month Top Line Growth and a 35% Increase in Profitability; Raises Full-Year Profitability Guidance
First Half 2025 Total Revenues were $88.8 Million, up 11% Year-over-Year; Revenues for 2025 Second Quarter were $44.8 Million, up 5% Year-over-Year First Half 2025 Adjusted EBITDA of $22.5 Million, up 35% Year-over-Year and Representing 25% Margin of …